DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Finn RS, Ducreux M, Qin S. , et al.
IMbrave150: a randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.
J Clin Oncol 2018;
36: TPS4141-TPS4141
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.